XstalBio Introduces CentuRecon

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2013, Volume 37, Issue 9

CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration.

CentuRecon, a patented reconstitution technology, decreases the preparation time of high concentration protein solutions from dry powder formulations and makes delivery faster and safer, according to the company. CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration and produces foam-free solutions that maximize the deliverable dose. CentuRecon is compatible with standard lyophilized formulations and diluents and with normal vials, cartridges, or dual-chamber syringes. It can be used for very high concentration and/or viscous solutions that may need to be delivered with injection devices.

XstalBio